Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.

AVCT

Avacta (AVCT)

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:LSE:AVCT
DataOraFonteTitoloSimboloCompagnia
10/03/202508:00RNS Regulatory NewsAvacta Group PLC Avacta to Present at Leerink Healthcare ConferenceLSE:AVCTAvacta
07/03/202513:42Alliance NewsAlliance NewsAvacta sells Launch Diagnostics; reports "promising" efficacy dataLSE:AVCTAvacta
07/03/202509:40RNS Regulatory NewsAvacta Group PLC Avacta announces data update for AVA6000LSE:AVCTAvacta
07/03/202508:42RNS Regulatory NewsAvacta Group PLC Avacta to sell Launch DiagnosticsLSE:AVCTAvacta
04/02/202508:00RNS Regulatory NewsAvacta Group PLC Appointment of Joint BrokerLSE:AVCTAvacta
21/01/202516:09RNS Regulatory NewsAvacta Group PLC Issue of Equity and Total Voting RightsLSE:AVCTAvacta
16/01/202508:00RNS Regulatory NewsAvacta Group PLC Avacta Announces Data from AVA6000 Phase 1 trialLSE:AVCTAvacta
13/01/202515:59Alliance NewsAlliance NewsEXECUTIVE CHANGES: Various Eateries hires Young's executive as CEOLSE:AVCTAvacta
13/01/202508:00RNS Regulatory NewsAvacta Group PLC Avacta Appoints Chief Financial OfficerLSE:AVCTAvacta
12/12/202408:00RNS Regulatory NewsAvacta Group PLC Completion of Dose Escalation and RDE ArmsLSE:AVCTAvacta
30/10/202408:00RNS Regulatory NewsAvacta Group PLC R&D Spotlight focusing on pipeline advancesLSE:AVCTAvacta
28/10/202408:00RNS Regulatory NewsAvacta Group PLC Block Listing Six Monthly ReturnLSE:AVCTAvacta
24/10/202408:00RNS Regulatory NewsAvacta Group PLC Avacta Reports Pipeline Avances at EORTCLSE:AVCTAvacta
21/10/202415:31Alliance NewsAlliance NewsAvacta partners with Tempus to enable AI-driven drug developmentLSE:AVCTAvacta
21/10/202408:00RNS Regulatory NewsAvacta Group PLC Avacta and Tempus Enter Strategic CollaborationLSE:AVCTAvacta
17/10/202414:39Alliance NewsAlliance NewsAvacta expands pipeline with two novel preclinical assetsLSE:AVCTAvacta
17/10/202408:00RNS Regulatory NewsAvacta Group PLC Avacta Expands its PipelineLSE:AVCTAvacta
15/10/202412:18Alliance NewsAlliance NewsEXECUTIVE CHANGES: PHSC co-founder and Deltic Energy CEO departLSE:AVCTAvacta
15/10/202408:00RNS Regulatory NewsAvacta Group PLC Avacta appoints Chief Scientific OfficerLSE:AVCTAvacta
15/10/202408:00UK RegulatoryAvacta Group strengthens executive team with appointment of Michelle Morrow, PhD as Chief Scientific OfficerLSE:AVCTAvacta
10/10/202408:00RNS Regulatory NewsAvacta Group PLC Avacta Unveils Pipeline Expansion at EORTC 2024LSE:AVCTAvacta
10/10/202408:00UK RegulatoryAvacta to Unveil Pipeline Expansion and Novel, Next-Generational Targeted Cancer Therapy Programs at 2024 EORTC-NCI-AACR SymposiumLSE:AVCTAvacta
30/09/202414:14Alliance NewsAlliance NewsEARNINGS: Brighton Pier gives downbeat outlook; Seeen "has momentum"LSE:AVCTAvacta
30/09/202408:00RNS Regulatory NewsAvacta Group PLC Interim ResultsLSE:AVCTAvacta
16/09/202408:00RNS Regulatory NewsAvacta Group PLC Avacta Reported Updated Phase 1 Data of AVA6000LSE:AVCTAvacta
14/09/202409:00UK RegulatoryAvacta Reports Updated Phase 1 Clinical Data of AVA6000 at the European Society for Medical Oncology (ESMO) Congress Demonstrating Multiple Ongoing, Durable Responses in Solid TumorsLSE:AVCTAvacta
12/09/202408:00RNS Regulatory NewsAvacta Group PLC Notice of ResultsLSE:AVCTAvacta
09/09/202408:00RNS Regulatory NewsAvacta Group PLC Avacta to present clinical data at ESMO CongressLSE:AVCTAvacta
09/09/202400:05UK RegulatoryAvacta to present updated clinical data on AVA6000 at the European Society for Medical Oncology (ESMO) CongressLSE:AVCTAvacta
02/09/202416:53RNS Regulatory NewsAvacta Group PLC Director/PDMR Shareholdings and TVRLSE:AVCTAvacta
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:LSE:AVCT
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network